Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First vs Second Tier Antibiotics for SSI in Hysterectomy with Penicillin Allergy
NCT04401553Phase 4Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Aug 2024
- Primary completion
- Aug 2026
01
Overview
Phase 4, randomised, single-blind trial in surgical site infection (SSI) (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Surgical site infections during early postoperative period at 30 days. Planned start Aug 2024; status: withdrawn.
02
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04401553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04401553.